They paid 20 million for that compound. I would have thought the patents were a given. It's pretty meaningless. Also, I'm glad to see in the exchange of analyses over the merger the acknowledgement that the HPV vaccine will render this treatment redundant. 20 million for a redundant treatment.
Vaxart Merger, page-27
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)